Oyster Point Pharma OverviewOyster Point Pharma Other Income Expense Net
Other Income/Expense Net for OYST.
Quarterly Other Income/Expense
-$3.50M
↓ 287.47% YoY
As of Sep 30, 2022
Annual Other Income/Expense (TTM)
-$12.33M
↓ 1318.53% YoY
Trailing 12 months ending Sep 30, 2022